Your session is about to expire
← Back to Search
Slow Breathing for Spinal Cord Injury (SCOGA Trial)
N/A
Waitlist Available
Research Sponsored by Spaulding Rehabilitation Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1,5 hour during slow-breathing
Awards & highlights
No Placebo-Only Group
Summary
This trial will study how slow breathing affects heart rate & blood pressure in people with spinal cord injuries, using traditional yoga breathing exercises. #SCI #YogaBreathing
Who is the study for?
This trial is for adults aged 18-60 with spinal cord injury who are wheelchair users, have a BMI of 18.5 - 35 kg/m2, and can follow instructions. It's not for those who smoke, have irregular heartbeats, high blood pressure, take certain heart medications (except for blood pressure support), or have cancer, diabetes, epilepsy/neurological diseases, kidney disease or coronary artery disease.
What is being tested?
The study examines the effects of slow 'yogic' breathing exercises on heart rate and blood pressure in individuals with spinal cord injuries to understand its potential benefits on the cardiovascular system.
What are the potential side effects?
Since this trial involves traditional breathing exercises without medication or invasive procedures, significant side effects are not anticipated. However, participants may experience changes in their respiratory patterns.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1,5 hour during slow-breathing
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1,5 hour during slow-breathing
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Heart Rate Variability
beat-by-beat arterial pressure
beat-by-beat limb blood flow
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Spinal Cord Injury SubjectsExperimental Treatment1 Intervention
20 medically stable male and female subjects between 18 and 60 years old, BMI between 18.5-35 kg/m2, with a history of SCI and who use a wheelchair were included. Participants that did not speak English or with a history of renal, neurological, or coronary artery disease, cancer, diabetes, significant arrhythmia smoking, or using cardioactive medications were excluded.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Slow Breathing
2009
N/A
~110
Find a Location
Who is running the clinical trial?
Spaulding Rehabilitation HospitalLead Sponsor
139 Previous Clinical Trials
11,068 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You currently smoke or use tobacco products.You have a serious irregular heartbeat.Your blood pressure is higher than 140/90 mmHg.You are currently taking heart medication, except for medication to support blood pressure.Your body mass index is between 18.5 and 35.You have cancer.You have diabetes.You have epilepsy or other brain-related diseases.You have kidney disease.You use a wheelchair.You have heart disease involving the arteries that supply blood to the heart.You are between 18 and 60 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Spinal Cord Injury Subjects
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.